Diagnostic predictability of hepatocellular carcinoma tumor markers in patients waiting for living donor liver transplantation
Open Access
- 31 May 2022
- journal article
- research article
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 34-42
Abstract
Cheon-Soo Park, Yong-Kyu Chung, Sung-Hwa Kang, Shin Hwang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0012Keywords
This publication has 22 references indexed in Scilit:
- Biomarkers for Hepatocellular CarcinomaInternational Journal of Hepatology, 2012
- High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinomaCancer, 2009
- Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver DiseaseClinical Cancer Research, 2008
- Alpha-Fetoprotein, Stem Cells and Cancer: How Study of the Production of Alpha-Fetoprotein during Chemical Hepatocarcinogenesis Led to Reaffirmation of the Stem Cell Theory of CancerTumor Biology, 2008
- Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesisJournal of Viral Hepatitis, 2004
- The des‐γ‐carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinomaCancer, 2003
- Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adultsGut, 2003
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984
- Structure and Function of Alpha-FetoproteinAnnual Review of Medicine, 1977